CORT Q4 2022 Earnings — Corcept Therapeutics Incorporated Revenue & Financial Results | Market Cap Arena

CORTCorcept Therapeutics Incorporated

$4B

Q4 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$103M+4.3% YoY

Gross Profit

$102M98.6% margin

Operating Income

$22M21.8% margin

Net Income

$17M16.1% margin

EPS (Diluted)

$0.14

QoQ Revenue Growth

+1.3%

Cash Flow

Operating Cash Flow

$33M

Free Cash Flow

$33M

Stock-Based Comp.

$11M

Balance Sheet

Total Assets

$583M

Total Liabilities

$82M

Stockholders' Equity

$502M

Cash & Equivalents

$66M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$103M	$99M	+4.3%
Gross Profit	$102M	$97M	+4.2%
Operating Income	$22M	$37M	-38.6%
Net Income	$17M	$32M	-48.2%